syndrom
ss
connect
tissu
diseas
character
chronic
inflamm
exocrin
gland
mainli
salivari
lachrym
gland
case
system
involv
occur
alon
primari
ss
pss
accompani
system
diseas
rheumatoid
arthriti
ra
connect
tissu
diseas
like
autoimmun
diseas
pathogenesi
reli
aberr
activ
immun
system
selfepitop
especi
salivari
gland
situat
b
lymphocyt
play
decis
role
may
undergo
neoplast
transform
minor
case
fact
ss
progress
b
cell
lymphoma
usual
mucosaassoci
lymphoid
tissu
malt
lymphoma
initi
trigger
ss
still
unknown
subject
permiss
genet
background
like
develop
diseas
follow
microbi
infect
polymorph
variant
gene
involv
immun
respons
associ
suscept
ss
microorgan
hepat
c
viru
hcv
epsteinbarr
viru
ebv
lymphotrop
viru
type
consid
put
induc
diseas
well
implic
carcinogenesi
mechan
mean
virus
induc
precancer
modif
infect
cell
still
debat
may
includ
epigenet
alter
aberr
gene
transcript
follow
viral
genom
insert
host
cell
dna
ss
patient
character
alter
epigenet
background
may
vari
wide
depend
anatom
site
clinic
manifest
epigenet
alter
aberr
methyl
histon
deacetyl
microrna
express
ad
genet
predisposit
may
explain
basi
complex
crosstalk
host
cell
microbiom
recent
hypothesis
dysbiosi
chang
composit
stabl
commens
microbiom
crucial
step
pathogenesi
mani
autoimmun
diseas
guid
differenti
activ
cell
belong
innat
adapt
immun
system
studi
patient
experiment
model
ss
describ
oral
gut
dysbiosi
term
bacteri
composit
data
concern
microorgan
virus
seem
play
import
role
pathogenesi
diseas
latent
viral
infect
retroel
integr
host
dna
may
impair
epigenet
machineri
prime
cell
develop
proinflammatori
neoplast
phenotyp
aim
narr
review
describ
current
evid
concern
role
infect
dysbiosi
play
epigenet
control
gene
express
ss
patient
possibl
implic
b
cell
lymphomagenesi
search
pubm
googl
scholar
databas
experiment
clinic
studi
potenti
associ
microbiota
epigenet
aberr
risk
b
cell
lymphoma
ss
patient
use
combin
word
syndrom
b
cell
lymphoma
epigenet
microbiom
microbiota
virom
dysbiosi
infect
select
pertin
articl
prioriti
given
systemat
review
metaanalys
recent
publish
origin
report
articl
written
languag
english
exclud
ninetytwo
paper
publish
last
year
select
result
divid
concern
pathogenesi
ss
particular
focu
epigenet
machineri
may
mean
pathogen
control
final
phenotyp
host
cell
concern
role
microbi
agent
determin
ss
ssassoci
lymphoma
relationship
malt
lymphoma
ss
chronic
autoimmun
epithel
whose
pathogenesi
seem
trigger
environment
agent
act
permiss
genet
background
genet
suscept
subject
microbi
agent
may
induc
aberr
activ
innat
adapt
immun
mucos
epitheli
cell
far
innoc
bystand
contribut
inflammatori
cascad
secret
cytokin
recruit
proinflammatori
cell
bloodstream
adapt
immun
involv
part
immun
respons
b
lymphocyt
hallmark
diseas
product
autoantibodi
ribonucleoprotein
complex
rossa
lassb
may
appear
sever
year
symptom
onset
presenc
classic
infiltr
b
lymphocyt
plasma
cell
minor
salivari
gland
biopsi
organis
germin
centr
mandatori
make
diagnosi
score
diseas
sever
understand
mechan
underli
pathogenesi
ss
crucial
import
order
abl
discrimin
step
lead
b
cell
transform
promptli
identifi
patient
risk
lymphomagenesi
genomewid
associ
studi
gwa
ss
patient
identifi
interferoni
ifni
ifnii
signatur
possibl
induc
microbi
trigger
stimul
autoimmun
three
larg
gwa
ss
patient
control
carri
far
respect
consid
caucasian
han
chines
popul
subject
european
asian
descent
found
associ
ss
signal
transduc
activ
transcript
tumor
necrosi
factoralphainduc
protein
major
histocompat
complex
mhc
gene
ifn
regulatori
factor
involv
regul
innat
adapt
immun
respons
howev
studi
bias
interraci
variabl
heterogen
clinic
manifest
nonspecif
natur
ifn
signatur
also
associ
autoimmun
diseas
system
lupu
erythematosu
sle
ra
absenc
evalu
patient
malt
lymphoma
address
studi
smaller
homogen
cohort
worth
note
associ
highlight
presum
role
pathogenesi
ss
insofar
mediat
involv
viral
infect
lymphomagenesi
bind
cellular
dna
aminotermin
domain
regul
transcript
gene
involv
inflamm
type
ifn
cytokin
includ
studi
shown
may
induc
permiss
background
latent
viral
infect
due
ebv
favour
process
b
cell
transform
malign
clone
wherea
other
report
may
prevent
develop
hepatocellular
carcinoma
mediat
characterist
downregul
hcv
infect
ebv
hcv
associ
ss
may
give
rise
aberr
activ
immun
system
genet
predispos
subject
moreov
virus
may
develop
latent
phase
induc
genet
chang
insid
host
cell
thu
lead
malign
phenotyp
interestingli
demonstr
minor
salivari
gland
ss
patient
develop
b
lymphoma
type
ii
ifn
signatur
product
overpass
type
ifn
signatur
repres
cascad
secret
lymphocyt
natur
killer
cell
macrophag
play
antimicrobi
role
increas
level
lymphomagenesi
may
repres
attempt
immun
system
counteract
chronic
infect
inflammatori
cascad
trigger
glandular
epitheli
cell
undergo
apoptot
proinflammatori
process
recruit
cell
belong
innat
acquir
immun
histolog
studi
salivari
gland
demonstr
presenc
infiltr
macrophag
dendrit
cell
natur
killer
cell
b
lymphocyt
b
lymphocyt
main
protagonist
respons
cytokin
releas
antigen
present
product
autoantibodi
celldepend
cellindepend
manner
releas
larg
amount
antibodi
circul
lead
deposit
immun
complex
develop
system
complic
case
time
b
cell
malt
may
undergo
aberr
monoclon
prolifer
end
develop
nonhodgkin
lymphoma
marker
detect
minor
salivari
gland
infiltr
peripher
blood
includ
b
cellactiv
factor
baff
receptor
reflect
activ
b
cell
ss
among
fetal
liverlik
tyrosin
kinas
particularli
interest
serum
concentr
directli
associ
risk
b
lymphocyt
transform
baff
play
crucial
role
b
lymphocyt
surviv
matur
interact
receptor
b
cell
matur
antigen
bcma
transmembran
activ
calcium
modul
cyclophilin
ligand
caml
interactor
taci
baff
receptor
express
b
lymphocyt
overexpress
baff
receptor
serum
tissu
correl
risk
autoimmun
disord
b
cellderiv
malign
progressionfre
surviv
chemotherapi
interestingli
nezo
et
al
report
polymorph
variant
baff
gene
associ
increment
risk
develop
lymphoma
ss
patient
allel
baff
gene
promot
confer
high
risk
compar
healthi
control
similar
studi
show
variant
baffr
gene
associ
ss
ssassoci
malt
lymphoma
especi
younger
patient
immun
system
cell
may
contribut
counteract
escap
malign
clone
exampl
presenc
autoreact
cell
autoimmun
infiltr
minor
salivari
gland
usual
associ
better
prognosi
limit
risk
lymphoma
cell
divid
cluster
differenti
cell
latter
numer
aggress
form
ss
usual
associ
lymphoma
risk
multiom
studi
wholeblood
transcriptom
serum
protein
peripher
immunophenotyp
japanes
ss
patient
control
reveal
lymphocyt
signatur
associ
express
disintegrin
metalloproteas
adam
thu
indic
activ
phenotyp
lymphocyt
involv
defenc
intracellular
pathogen
virus
may
repres
link
viral
infect
lymphomagenesi
context
increas
lymphocyt
patient
sever
ss
prone
develop
lymphoma
may
repres
attempt
immun
system
prevent
infect
b
cell
prolifer
among
lymphocyt
helper
cell
associ
sever
pictur
glandular
inflamm
known
highli
pathogen
autoimmun
diseas
ra
spondyloarthritid
main
produc
cytokin
lie
basi
autoimmun
also
character
high
degre
plastic
transdifferenti
phenotyp
depend
cytokin
milieu
presenc
lymphocyt
foment
inflamm
favour
synthesi
proinflammatori
cytokin
chemokin
immun
epitheli
cell
lymphocyt
especi
promot
differenti
b
lymphocyt
plasma
cell
final
product
autoantibodi
furthermor
product
b
cell
stimul
differenti
phenotyp
thu
provid
loop
although
exact
role
lymphomagenesi
still
controversi
increas
percentag
circul
lymphocyt
report
patient
b
cell
lymphoma
invers
relat
treatment
respons
accordingli
presenc
cell
infiltr
may
simultan
strengthen
immunosurveil
transform
b
cell
favour
surviv
prolifer
thu
play
doubleedg
role
inflamm
lymphomagenesi
addit
acquir
immun
activ
innat
immun
system
cell
may
amplifi
local
system
inflamm
provid
direct
link
infect
autoimmun
lymphomagenesi
tolllik
receptor
tlr
abundantli
express
cell
belong
innat
immun
system
may
crossrecogn
molecul
damag
cell
includ
cancer
cell
damageassoci
molecular
pattern
damp
pathogen
pathogenassoci
molecular
pattern
pamp
ss
patient
stimul
plasma
membran
peripher
blood
mononuclear
cell
pbmc
bacteri
compound
lipopolysaccharid
lp
induc
product
whose
effect
b
lymphocyt
discuss
salivari
epitheli
gland
cell
recogn
viral
genom
mean
intracellular
induc
express
intercellular
adhes
molecul
mhc
class
baff
promot
activ
prolifer
b
cell
activ
innat
immun
system
via
tlr
pathway
also
found
proteom
studi
ss
patient
saliva
aberrantli
express
molecul
famili
protein
interestingli
mani
molecul
produc
respons
infect
alter
commens
flora
chang
salivari
proteom
profil
observ
ss
patient
develop
malt
lymphoma
thu
underlin
possibl
microbi
insult
may
give
rise
inflamm
neoplast
transform
ss
patient
accordingli
use
proteom
search
salivari
marker
may
use
mean
distinguish
healthi
ss
subject
allow
earli
identif
patient
risk
develop
malt
lymphoma
number
studi
demonstr
patient
ss
autoimmun
diseas
impair
epigenet
profil
consist
aberr
dna
methyl
histon
deacetyl
andor
product
noncod
microrna
micelirichard
et
al
analys
methyl
pbmc
ss
patient
control
use
infinium
human
methyl
k
beadchip
found
signific
differ
methyl
pattern
patient
control
b
lymphocyt
lymphocyt
epigenet
modul
gene
encod
proinflammatori
protein
modul
associ
eular
syndrom
diseas
activ
index
essdai
product
antirossa
antilassb
autoantibodi
author
found
differenti
methyl
gene
ss
patient
develop
b
cell
lymphoma
includ
tumor
necrosi
factor
tnf
tnf
receptor
superfamili
member
differ
express
gene
relat
intracellular
pathogen
infect
tlr
ifn
pathway
transform
b
lymphocyt
reinforc
hypothesi
crosslink
infect
epigenet
lymphomagenesi
interest
note
chang
global
methyl
detect
interspers
dna
alu
sequenc
long
interspers
element
line
usual
site
retrovir
integr
wherea
involv
cpg
island
usual
associ
promot
region
altorok
et
al
describ
differ
pattern
methyl
peripher
cell
caucasian
patient
pss
control
found
total
differ
methyl
gene
hypomethyl
consequ
overexpress
among
lta
particularli
interest
role
activ
innat
acquir
immun
respons
lymphoid
organogenesi
antivir
respons
therefor
accord
studi
b
lymphocyt
ss
patient
character
aberr
epigenet
control
gene
involv
microbi
defenc
inflamm
cell
surviv
final
converg
activ
phenotyp
author
found
nearli
homolog
methyl
pattern
gene
taken
salivari
gland
epitheli
cell
peripher
b
lymphocyt
obtain
ss
patient
control
demonstr
differ
methyl
gene
relat
calcium
pathway
winglesstyp
mmtv
integr
site
famili
wnt
signal
known
associ
oncogenesi
cell
surviv
calcium
pathway
involv
oxid
stress
unfold
protein
respons
upr
due
rough
endoplasm
reticulum
rer
stress
demonstr
salivari
gland
epitheli
cell
phenotyp
character
rer
stress
alter
mucin
protein
secret
may
relat
unfold
protein
retain
rer
may
activ
innat
respons
nuclear
factor
kappalightchainenhanc
activ
b
cell
activ
pathway
nlr
famili
pyrin
domaincontain
inflammasom
inflammasom
multiprot
complex
elicit
recognit
pathogen
domain
may
deriv
microorgan
cellular
debri
cooper
tlr
pathway
innat
immun
respons
activ
inflammasom
epitheli
cell
ss
patient
demonstr
histolog
studi
five
ss
patient
concomit
malt
lymphoma
signatur
salivari
gland
b
lymphocyt
seem
correl
directli
risk
lymphomagenesi
final
author
describ
hypomethyl
gene
involv
ifn
pathway
whole
blood
b
lymphocyt
minor
salivari
gland
biopsi
pss
patient
clear
epigenet
aberr
epitheli
salivari
gland
dictat
activ
transform
b
lymphocyt
malign
cell
possibl
paracrin
mechan
interestingli
studi
agre
hyperexpress
interferoninduc
protein
b
lymphocyt
whole
blood
ss
patient
protein
prevent
replic
variou
human
virus
includ
hcv
yellow
fever
viru
west
nile
viru
chikungunya
viru
human
immunodefici
thu
suggest
alter
methyl
viral
etiolog
methyl
cpg
island
main
mechan
underli
inactiv
x
chromosom
femal
ss
preval
women
impair
methyl
x
chromosom
contain
largest
number
gene
code
molecul
relat
immun
respons
includ
suggest
demonstr
salivari
gland
epitheli
cell
ss
patient
x
chromosom
inactiv
process
depend
sequenc
aberr
epigenet
chang
may
occur
case
unusu
insert
transposit
foreign
genom
materi
methylen
tetrahydrofol
reductas
mthfr
ratelimit
enzym
methyl
cycl
polymorph
variant
gene
associ
dna
damag
increas
risk
autoimmun
lymphoprolif
disord
accord
recent
studi
ss
patient
nonmalt
lymphoma
increas
express
mthfr
allel
reduc
express
mthfr
c
c
allel
compar
healthi
control
wherea
signific
differ
mthfr
gene
polymorph
emerg
ss
patient
malt
lymphoma
consid
genotyp
associ
reduc
dna
methyl
genom
instabl
thu
provid
explan
mutagenesi
nonmalt
lymphoma
may
distinct
epigenet
pathway
malt
lymphoma
addit
dna
methyl
aberr
microrna
express
also
describ
pathogenesi
ss
microrna
small
noncod
rna
filament
nucleotid
length
control
gene
express
mainli
pair
region
target
mrna
although
mechan
control
also
describ
aberr
microrna
express
may
relat
exagger
inflammatori
respons
studi
pbmc
salivari
gland
epitheli
cell
detect
alter
microrna
cluster
express
ss
patient
report
microrna
upregul
pbmc
salivari
gland
ss
patient
microrna
downregul
salivari
gland
cluster
upregul
lymphocyt
patient
lymphoprolif
disord
downregul
patient
ss
express
microrna
tissuerel
may
induc
infecti
stimuli
exampl
infect
due
helicobact
pylori
seem
modul
express
microrna
control
cell
prolifer
surviv
floch
et
al
demonstr
gastric
malt
lymphoma
mous
model
chronic
helicobact
pylori
infect
may
induc
overexpress
microrna
prevent
transcript
gene
code
proapoptot
protein
tumor
protein
nuclear
protein
microrna
control
product
antibodi
includ
autoantibodi
other
may
belong
virus
infect
host
cell
case
ebv
infect
viral
microrna
ebv
microrna
may
overexpress
infect
cell
favour
cell
surviv
prolifer
thu
pave
way
develop
prolif
diseas
express
microrna
involv
b
cell
growth
enhanc
lymphoma
overexpress
may
driven
ebv
infect
two
ebvencod
protein
latent
membran
eb
nuclear
microbi
infect
may
therefor
modul
cell
fate
mean
epigenet
control
lead
final
develop
proinflammatori
neoplast
phenotyp
human
microbiom
consist
trillion
commens
bacteria
protozoa
fungi
virus
live
insid
human
bodi
wide
consid
independ
organ
per
se
capabl
interact
host
cell
guid
differenti
immun
system
led
grow
interest
investig
role
alter
microbiom
composit
dysbiosi
pathogenesi
autoimmun
neoplast
diseas
commens
microorgan
compet
pathogen
substrat
usual
induc
immun
respons
physic
barrier
confin
specif
anatom
site
imped
entri
bloodstream
activ
immunosurveil
exert
resid
circul
immun
cell
gut
harbour
major
commens
microorgan
variat
gut
flora
associ
imbal
regul
cell
ratio
although
microbiom
quit
stabl
cours
life
chang
composit
may
dictat
variou
factor
includ
antibiot
therapi
diet
combin
genet
mutat
resid
microorgan
favour
genet
background
host
cell
may
alter
balanc
induc
dysbiosi
condit
character
emerg
pathogen
phyla
lie
basi
mani
autoimmun
diseas
may
elicit
steril
inflamm
prime
innat
acquir
immun
system
pathogen
deriv
protein
nucleic
acid
capabl
interact
protein
nucleotidebind
domainlik
receptor
nlr
absent
melanoma
receptor
alr
pyrin
activ
inflammasom
variou
studi
ss
patient
anim
model
demonstr
dysbiosi
gut
oral
mucosa
patient
ss
may
develop
antibodi
highli
conserv
microbi
protein
staphylococcu
aureu
escherichia
coli
result
molecular
mimicri
crossreact
mitochondri
selfantigen
may
explain
symptom
fatigu
continu
attempt
defend
human
bodi
pathogen
may
also
explain
aberr
activ
b
lymphocyt
plasma
cell
subsequ
product
antimicrobi
autoantibodi
character
ss
studi
microbi
balanc
oral
mucosa
ss
patient
led
discord
find
exampl
risk
periodont
seem
higher
ss
control
although
ss
mous
model
patient
show
specif
microbi
gut
signatur
preval
enterobacteriacea
bifidobacteriacea
final
respons
autoimmun
viral
infect
especi
due
ebv
hepat
virus
quit
frequent
ss
patient
virus
share
abil
integr
host
cell
genom
use
transcript
machineri
chang
latent
lytic
infect
ultim
respons
dna
break
aberr
gene
transcript
ebv
infect
associ
risk
develop
lymphoma
viru
infect
hematopoiet
epitheli
cell
escap
clearanc
immun
system
express
differ
antigen
differ
stage
infect
latenc
express
six
ebna
immortalis
b
lymphocyt
prevent
activ
pathway
enhanc
kinas
activ
comparison
control
colombian
studi
ss
patient
found
signific
increas
antiebv
earli
antigen
ebvea
immunoglobulin
g
igg
indic
lytic
infect
directli
correl
antilassb
antibodi
titr
invers
titr
ebvea
structur
function
similar
protooncogen
b
cell
lymphoma
involv
cell
prolifer
surviv
carcinogenesi
ebvinfect
epitheli
cell
b
lymphocyt
may
therefor
express
differ
viral
antigen
depend
phase
infect
rel
chang
transcriptom
may
underli
emerg
neoplast
phenotyp
retrovirus
insert
host
cell
dna
modul
transcript
cellular
gene
gener
aberr
transcript
activ
innat
immun
respons
infect
due
human
immunodefici
type
human
lymphotrop
viru
induc
onset
sicca
syndrom
studi
anim
model
patient
ss
shown
presenc
retrovir
antigen
genom
sequenc
salivari
gland
well
serum
antibodi
react
retrovir
gag
protein
addit
viral
infect
human
virom
mainli
consist
bacteriophag
may
induc
bacteri
dysbiosi
associ
develop
autoimmun
diseas
inflammatori
bowel
diseas
type
diabet
howev
still
data
avail
concern
role
play
commens
virom
pathogenesi
ss
cellular
genom
also
contain
retroel
latent
viral
insert
may
activ
inflammasom
element
account
nearli
human
genom
movabl
transposon
roughli
fall
two
group
long
termin
repeat
ltr
contain
gene
revers
transcriptas
without
includ
line
short
interspers
element
sine
alu
retrotranscrib
affect
transcript
gene
adjac
insert
site
cell
usual
capabl
distinguish
exogen
nucleic
acid
genom
basi
molecular
structur
length
nucleotid
composit
evid
indic
endogen
alu
retroel
form
complex
cellular
ribonucleoprotein
activ
tlr
pathway
sine
rna
directli
induc
inflammasom
interestingli
activ
uncap
nucleic
acid
may
belong
pathogen
virus
damag
cell
eg
cancer
cell
nucleic
acid
ribonucleoprotein
activ
inflammasom
contribut
progress
sle
shown
activ
increas
pbmc
salivari
glandinfiltr
macrophag
ss
patient
activ
inflammasom
ss
epitheli
cell
directli
associ
likelihood
develop
b
cell
lymphoma
accord
result
fascin
ex
vivo
studi
minor
salivari
gland
biopsi
ss
patient
like
aberr
methyl
insid
epitheli
cell
concomit
express
open
read
frame
protein
would
induc
recognit
activ
pathway
gener
type
ifn
signatur
reactiv
retroel
reli
differ
pattern
methyl
shown
minor
salivari
gland
tissu
ss
patient
high
risk
lymphoma
increas
methyl
element
concomitantli
reduc
express
methyl
enzym
includ
dna
methyltransferas
methyl
cpgbind
protein
compar
patient
low
risk
howev
still
lack
studi
retroel
ss
patient
experiment
model
still
uncertainti
concern
role
trigger
diseas
complic
includ
b
cell
lymphoma
syndrom
still
unclear
whether
epigenet
chang
induc
chronic
latent
infect
trigger
develop
ss
ssassoci
lymphoma
genet
predispos
subject
pathogen
steril
infect
may
contribut
diseas
chronic
stimul
b
lymphocyt
clone
patient
pss
produc
polyclon
antibodi
increas
level
dim
plasmablast
follow
influenza
vaccin
result
hyperact
b
cell
like
autoimmun
diseas
ss
primari
site
infect
often
unknown
possibl
lymphoma
may
trigger
previou
infect
epigenet
prime
immun
system
whose
final
repercuss
affect
district
may
far
origin
site
infect
support
hypothesi
experiment
fasdefici
mice
model
shown
infect
murin
cytomegaloviru
follow
develop
salivari
gland
infiltr
undetect
viru
addit
multipl
consecut
infect
may
epigenet
modifi
target
cell
develop
final
cancer
proinflammatori
phenotyp
risk
b
cell
lymphoma
increas
durat
ss
approxim
first
five
year
diseas
year
patient
lymphadenopathi
parotid
enlarg
palpabl
purpura
cryoglobulinemia
low
serum
level
frequent
ssassoci
lymphoma
malt
lymphoma
ss
patient
may
develop
lymphoprolif
disord
follicular
lymphoma
diffus
larg
b
cell
lymphoma
malt
lymphoma
develop
margin
zone
b
cell
probabl
influenc
sever
diseas
term
autoantibodi
product
histolog
lesion
symptom
depend
anatom
site
margin
zone
lymphoma
divid
classic
malt
lymphoma
aris
lymphoid
follicl
associ
mucosa
splenic
margin
zone
lymphoma
nodal
margin
zone
lymphoma
genet
epigenet
chang
found
form
includ
chromosom
trisomi
singlenucleotid
polymorph
methyl
chang
phenomena
lead
aberr
activ
promot
surviv
activ
b
cell
worth
note
somat
mutat
found
approxim
malt
lymphoma
dysregul
gene
also
associ
ss
gwa
note
studi
human
coronaviru
infect
cell
typic
upregul
order
guarante
effici
viral
replic
interest
experi
involv
homozyg
mice
carri
insert
heavi
light
chain
autoantibodi
react
nucleic
acid
nucleoprotein
shown
lymphomagenesi
may
relat
autoimmun
may
prevent
antibiot
treatment
gut
microbiota
specif
demonstr
may
simultan
respons
lymphocyt
transform
plasmablast
activ
final
product
autoantibodi
mice
prone
develop
multidistrict
infect
treat
antibiot
supplement
act
intestin
flora
show
lymphat
expans
risk
lymphoma
hypergammaglobulinemia
autoimmun
diseas
consequ
author
argu
chang
microbiota
may
guid
differenti
plasmablast
via
pathway
thu
lead
lymphoprolif
disord
autoimmun
impair
adapt
respons
pathogen
microorgan
nevertheless
spleen
section
mutant
wildtyp
mice
show
chang
margin
zone
architectur
start
point
malt
lymphoma
ss
patient
may
explain
differ
anatom
site
emerg
malign
b
cell
usual
surround
oral
mucosa
ss
patient
much
evid
malt
lymphoma
may
follow
infect
due
chlamydophila
psittaci
campylobact
jejuni
helicobact
pylori
sometim
erad
antibiot
therapi
earlier
phase
develop
bacteri
viral
infect
may
gener
autoimmun
mean
mechan
molecular
mimicri
polyclon
activ
b
lymphocyt
high
degre
inflamm
mirror
sever
clinic
manifest
laboratori
find
associ
risk
lymphomagenesi
higher
antirossa
antilassb
autoantibodi
titr
autoantibodi
posit
associ
increas
risk
b
cell
lymphoma
ss
patient
de
novo
onset
relaps
cancer
sle
patient
fascin
altern
chronic
infecti
stimul
b
cell
possibl
alter
gene
transcript
due
transpos
retrovir
element
latent
viru
infect
latent
ebv
transcript
includ
ebna
lmp
epigenet
regul
transcript
viral
oncoprotein
mean
cpg
methyl
histon
deacetyl
microrna
pair
super
enhanc
activ
mechan
may
act
immortalis
host
cell
lead
acquisit
transform
phenotyp
addit
ebv
express
two
noncod
rna
implic
b
cell
lymphomagenesi
human
endogen
retrovirus
herv
repres
ghost
longlat
viral
infect
whose
fulli
integr
genom
account
human
dna
hypothesis
herv
favour
diseas
onset
pathogen
model
multipl
sclerosi
ms
induc
mhc
share
b
lymphocyt
salivari
gland
epitheli
cell
infect
dysbiosi
may
modifi
cell
epigenet
machineri
consequ
control
gene
express
favour
inflamm
autoimmun
lymphomagenesi
particularli
epigenet
induct
transcript
gene
associ
microbi
recognit
eg
ifni
signatur
mean
aberr
methyl
histon
deacetyl
microrna
express
may
promot
hyperactiv
b
cell
respons
foreign
endogen
epitop
gener
bacteria
virus
endogen
retroel
addit
rer
stress
integr
retroel
may
favour
activ
inflammasom
caus
cell
dna
rearrang
repres
crucial
step
chronic
b
cell
activ
transform
step
final
converg
hyperproduct
autoantibodi
crossreact
antigen
local
system
inflamm
destruct
glandular
tissu
b
cell
transform
malign
clone
signal
transduc
activ
transcript
tumor
necrosi
factoralphainduc
protein
mhc
major
histocompat
complex
interferonregulatori
factor
ifn
interferon
tumor
necrosi
factor
receptor
superfamili
member
tlr
tolllik
receptor
herv
human
endogen
retrovirus
rer
rough
endoplasm
reticulum
repress
transcript
ms
caus
gene
ci
transcrib
herv
protein
respons
format
autoantigen
induc
rer
stress
final
cooper
infect
due
common
virus
ebv
influenza
viru
herv
usual
untrascrib
result
recent
rna
sequenc
experi
analys
behaviour
herv
murin
human
b
cell
variou
patholog
context
intrigu
author
examin
b
cell
herv
transcriptom
infecti
autoimmun
neoplast
condit
found
line
transcript
slightli
enhanc
sepsi
ltr
transcript
increas
respons
ifn
therefor
autoimmun
diseas
ltr
line
highli
express
b
cell
lymphoma
interestingli
herv
express
transform
b
cell
sequenc
express
b
cell
activ
inflammatori
stimulu
mous
b
cell
lymphoma
character
increas
express
proviru
may
acquir
infecti
follow
recombin
genom
strand
cancer
cell
escap
immunosurveil
result
cell
exhaust
increas
express
immun
checkpoint
prevent
immun
cell
activ
program
death
cytotox
lymphocyt
antigen
cancer
patient
treat
new
antitumor
agent
known
checkpoint
inhibitor
may
develop
autoimmun
symptom
ss
report
four
patient
treat
ipilimumab
nivolumab
although
interest
note
none
patient
posit
antirossa
antibodi
thu
suggest
differ
pathogenesi
latent
infect
may
epigenet
control
immun
checkpoint
demonstr
ebv
induc
express
downregul
microrna
b
cell
lymphoma
figur
summaris
presum
mechan
underli
pathogenesi
ss
ssrelat
b
cell
lymphoma
like
autoimmun
diseas
pathogenesi
ss
due
interact
favour
genet
background
environment
trigger
infect
dysbiosi
microorgan
may
induc
epigenet
modif
target
cell
tune
transcriptom
gener
activ
transform
phenotyp
establish
lymphoma
ss
patient
may
end
result
combin
genet
epigenet
dysbiosi
latent
infect
interestingli
increas
evid
retroel
integr
cell
dna
particip
process
lymphomagenesi
autoimmun
perhap
modul
express
key
gene
howev
still
lack
studi
specif
investig
precis
role
pathogenesi
ss
ssassoci
b
cell
lymphoma
